Kite Pharma

About:

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

Website: http://www.kitepharma.com

Twitter/X: kitepharma

Top Investors: Alta Partners, Two River, Bellco Capital, Riverbank Capital Securities, Arie Belldegrun

Description:

Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.

Total Funding Amount:

$335M

Estimated Revenue Range:

$10B+

Headquarters Location:

Los Angeles, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)kitepharma.com

Founders:

Arie Belldegrun, Joshua Kazam

Number of Employees:

1001-5000

Last Funding Date:

2015-12-10

IPO Status:

Delisted

© 2025 bioDAO.ai